September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Amol Akhade: Sacituzumab govitecan plus pembrolizumab shows PFS benefit in metastatic TNBC
Apr 22, 2025, 10:51

Amol Akhade: Sacituzumab govitecan plus pembrolizumab shows PFS benefit in metastatic TNBC

Amol Akhade, Senior consultant medical oncologist and hemato-oncologist at Suyog Cancer Clinics and Reliance Hospital, shared a post on LinkedIn:

“Today is day of press release.

Sacituzumab govitecan plus pembrolizumab shows PFS benefit over chemo plus Pembrolizumab in metastatic TNBC with CPS > 10.

Ascent 04 trial.

Looking forward to Magnitude of benifit.”

Amol Akhade: Sacituzumab govitecan plus pembrolizumab shows PFS benefit in metastatic TNBC